Move Over Mounjaro. Eli Lilly Has Another Blockbuster Opportunity in the Making, and No One Is Talking About It.
Weight loss treatments Mounjaro and Zepbound are the primary growth engines for Eli Lilly right now, but the company has ...
Nasdaq5d
Move Over Mounjaro. Eli Lilly Has Another Blockbuster Opportunity in the Making, and No One Is Talking About It.
For the last couple of years, the pharmaceutical sector has become infatuated with glucagon-like peptide 1 (GLP-1) agonists used to treat diabetes and help with chronic weight management.
Got $5,000? 2 Top Healthcare Stocks to Buy in 2025 and Hold Forever.
Eli Lilly started 2024 on a strong note but struggled during the second half of the year. The drugmaker dealt with several ...
2 Healthcare Stocks You Can Buy Right Now Before They Surge Even Higher
Eli Lilly (NYSE: LLY) sells many products across treatment areas, from immunology to neuroscience. The company sells ...
ClearBridge Large Cap Growth ESG Strategy Q4 2024 Commentary
The ClearBridge Large Cap Growth ESG Strategy underperformed its Russell 1000 Growth Index benchmark in the fourth quarter.
3 Richly Valued Stocks I'll Be Watching Like a Hawk in 2025
Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
Top Picks 2025- Madrigal Pharmaceuticals MDGL
Madrigal Pharmaceuticals Inc. (MDGL) is our top conservative biotech recommendation for 2025. The company is in the sweet spot and de-risked with the first FDA-approved drug for chronic liver ...
As RFK Jr.’s hearings begin, so will scrutiny on his familiarity with key health programs
The job Robert F. Kennedy Jr. is seeking is defined by the task of overseeing Medicare and Medicaid, which he's shown little ...
MoneyShow's Best Investment Ideas For 2025: Part 7
MoneyShow presents top investment ideas for 2024 from leading advisors. Part 7 includes Village Super Market, MARA Holdings, ...